Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression
The protocol paper16 and the primary analysis paper17 provide detailed information about the RESiLIENT trial (UMIN Clinical Trials Registry UMIN000047124, registered on 1 August 2022). The study was approved by